DLC1, DLC1 Rho GTPase activating protein, 10395

N. diseases: 144; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.060 Biomarker group BEFREE We show that DLC1 knockdown cooperates with Myc to promote hepatocellular carcinoma in mice, and that reintroduction of wild-type DLC1 into hepatoma cells with low DLC1 levels suppresses tumor growth in situ. 18519636 2008
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.060 Biomarker group LHGDN DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. 17292327 2007
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.060 AlteredExpression group BEFREE DLC-1 overexpression causes inhibition of in vitro growth of liver tumor cells and complete suppression of in vivo tumorigenicity of breast tumor cells. 12792785 2003
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.060 GeneticVariation group BEFREE A polymorphic microsatellite marker in intron 8 was used for mapping the gene (Arhgap7) to 20 cM on mouse chromosome 8 and for allelotyping of mouse liver tumor DNAs. 12034501 2002
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.060 AlteredExpression group BEFREE Despite the presence of Hp mRNA, Hp protein was not secreted by U-87MG cells as compared to the hepatoma cell line, HepG2, where Hp protein (approximately 46 kDa) was detected in the media. 11323115 2001
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.060 Biomarker group BEFREE DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. 11118037 2000